VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation
CompletedNot applicableNCT02741297
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The primary objective of this study is to characterize the real-world outcomes of spinal cord stimulation (SCS) therapy as an aid in the management of chronic intractable pain of the trunk, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain using the Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System with MultiWave Technology.
Study details
- Official title
- A Multi-Center Controlled Study to Characterize the Real-world Outcomes of High Rate Spinal Cord Stimulation Therapy Using Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System
- Conditions
- Interventions
- Device: Spinal Cord Stimulation (SCS) System
- Sponsor
- Boston Scientific Corporation
- Start date
- 2016-04-19
- Primary completion
- 2018-09-21
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Germany, Italy, Netherlands, United Kingdom
- Total sites listed
- 5
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Key Inclusion Criteria: * Complaint of persistent or recurrent low back pain for at least 180 days prior to Screening * Willing and able to comply with all protocol-required procedures and assessments/evaluations * Subject signed a valid, ethics committee (EC)-approved informed consent form (ICF) provided in local language Key Exclusion Criteria: * High surgical risk * Previous spinal cord stimulation trial or is already implanted with an active implantable device(s) (e.g. pacemaker, drug pump, implantable pulse generator) * A female who is pregnant, is breastfeeding, or is of childbearing potential and planning to get pregnant during the course of the study or not using adequate contraception. * Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study * Any diagnosis or condition that, in the clinician's best judgment, might confound reporting of study outcomes
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02741297